Biomarker-guided therapy by the numbers — a nephrology snapshot

About this Infographic

According to consensus recommendations, digital tooling shortens time-to-decision considerably, a finding echoed by several independent groups. In routine practice, variability between operators remains a key limitation, with meaningful differences between subgroups. According to consensus recommendations, cost considerations continue to shape adoption in smaller units, as discussed in the accompanying commentary. From a workflow perspective, cost considerations continue to shape adoption in smaller units, and this trend is expected to continue.

Across multiple cohorts, cost considerations continue to shape adoption in smaller units, as discussed in the accompanying commentary. Recent studies suggest that patient selection criteria deserve closer scrutiny, particularly in resource-constrained settings. In routine practice, cost considerations continue to shape adoption in smaller units, which has direct implications for daily practice. When protocols are compared, training and accreditation are decisive for reproducibility, which has direct implications for daily practice. Emerging evidence indicates that patient selection criteria deserve closer scrutiny, which has direct implications for daily practice.

Contrary to earlier assumptions, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice. Contrary to earlier assumptions, cost considerations continue to shape adoption in smaller units, with meaningful differences between subgroups.

When protocols are compared, training and accreditation are decisive for reproducibility, a finding echoed by several independent groups. Across multiple cohorts, integrating quantitative measures reduces subjective bias, with meaningful differences between subgroups.